Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer

Radiology

Volumn 265, Issue 3, 2012, Pages 790-798

  Chandarana, Hersh ^a   Rosenkrantz, Andrew B ^a   Mussi, Thais C ^a   Kim, Sooah ^a   Ahmad, Afshan A ^a   Raj, Sean D ^a   McMenamy, John ^a   Melamed, Jonathan ^a   Babb, James S ^a   Kiefer, Berthold ^b   Kiraly, Atilla P ^c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b Siemens Healthcare Sector   (Germany)

^c SIEMENS CORPORATE RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLEAR CELL RENAL CELL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOGRAM; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLARY RENAL CELL CANCER; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REGION OF INTEREST ENHANCEMENT; RETROSPECTIVE STUDY; WHOLE LESION ENHANCEMENT;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGING, THREE-DIMENSIONAL; KIDNEY NEOPLASMS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATTERN RECOGNITION, AUTOMATED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 84870028493     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12111281     Document Type: Article

References (30)

1. Sun M, Thuret R, Abdollah F, et al. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol 2011;59(1):135-141.
2. Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 2002;167(1):57-60. (Pubitemid 34024497)
3. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999;281(17):1628-1631. (Pubitemid 29211773)
4. Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology 1991;179(2):307-317.
5. Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005;173(6):1853-1862. (Pubitemid 40675199)
6. Reuter VE. The pathology of renal epithelial neoplasms. Semin Oncol 2006;33(5):534-543. (Pubitemid 44511979)
7. Young AN, Dale J, Yin-Goen Q, et al. Current trends in molecular classification of adult renal tumors. Urology 2006;67(5):873-880. (Pubitemid 43956434)
8. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003;27(5):612-624. (Pubitemid 36514472)
9. Leibovich BC, Lohse CM, Crispen PL, et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol 2010;183(4):1309-1315.
10. Teloken PE, Thompson RH, Tickoo SK, et al. Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. J Urol 2009;182(5):2132-2136.
11. Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007;356(2):125-134. (Pubitemid 46089673)
12. Powles T, Chowdhury S, Jones R, et al. Sunitinib and other targeted therapies for renal cell carcinoma. Br J Cancer 2011;104(5):741-745.
13. Chowdhury S, Choueiri TK. Recent advances in the systemic treatment of metastatic papillary renal cancer. Expert Rev Anticancer Ther 2009;9(3):373-379.
14. Volpe A, Kachura JR, Geddie WR, et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 2007;178(2):379-386. (Pubitemid 47030509)
15. Maturen KE, Nghiem HV, Caoili EM, Higgins EG, Wolf JS Jr, Wood DP Jr. Renal mass core biopsy: accuracy and impact on clinical management. AJR Am J Roentgenol 2007;188(2):563-570. (Pubitemid 46167760)
16. González-Michaca L, Chew-Wong A, Soltero L, Gamba G, Correa-Rotter R. Percutaneous kidney biopsy, analysis of 26 years: complication rate and risk factors; comment [in Spanish]. Rev Invest Clin 2000;52(2):125-131.
17. Pedrosa I, Chou MT, Ngo L, et al. MR classification of renal masses with pathologic correlation. Eur Radiol 2008;18(2):365-375. (Pubitemid 351234058)
18. Pedrosa I, Sun MR, Spencer M, et al. MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. RadioGraphics 2008;28(4):985-1003.
19. Sun MR, Ngo L, Genega EM, et al. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes - correlation with pathologic findings. Radiology 2009;250(3):793-802.
20. Herts BR, Coll DM, Novick AC, et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol 2002;178(2):367-372. (Pubitemid 34098041)
21. Zhang J, Lefkowitz RA, Ishill NM, et al. Solid renal cortical tumors: differentiation with CT. Radiology 2007;244(2):494-504. (Pubitemid 47080882)
22. Kim JK, Kim TK, Ahn HJ, Kim CS, Kim KR, Cho KS. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 2002;178(6):1499-1506. (Pubitemid 34547840)
23. Hecht EM, Israel GM, Krinsky GA, et al. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology 2004;232(2):373-378. (Pubitemid 38971275)
24. Wernecke J. The inventor mentor: Programming object-oriented 3D graphics with open inventor. Boston, Mass?: Addison-Wesley, 1994.
25. Chefd'hotel C, Hermosillo G, Faugeras O. Flows of diffeomorphisms for multimodal image registration. Proceedings of IEEE International Symposium on Biomedical Imaging, 2002; 753-756.
26. Grady L. Random walks for image segmentation. IEEE Trans Pattern Anal Mach Intell 2006;28(11):1768-1783. (Pubitemid 46405425)
27. Joanes DN, Gill CA. Comparing measures of sample skewness and kurtosis. J R Stat Soc Ser D (Statistician) 1998;47(1):183-189. (Pubitemid 128469067)
28. Sheir KZ, El-Azab M, Mosbah A, El-Baz M, Shaaban AA. Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol 2005;174(2):451-455; discussion 455.
29. Della Nave R, Foresti S, Pratesi A, et al. Whole-brain histogram and voxel-based analyses of diffusion tensor imaging in patients with leukoaraiosis: correlation with motor and cognitive impairment. AJNR Am J Neuroradiol 2007;28(7):1313-1319. (Pubitemid 47309665)
30. Chang YC, Huang CS, Liu YJ, Chen JH, Lu YS, Tseng WY. Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI. Phys Med Biol 2004;49(16):3593-3602.